BACKGROUND: Dietary studies designed to decrease the urinary albumin excretion rate (AER) typically reduce protein by increasing lower protein plant foods and decreasing higher protein animal products. STUDY DESIGN: We evaluated AER while increasing protein intake in the Dietary Approaches to Stop Hypertension (DASH) Trial (randomized, parallel group, 8 week controlled feeding). SETTING & PARTICIPANTS: 378 individuals without diabetes with prehypertension or stage I hypertension. INTERVENTION: The DASH diet, 18% energy from protein, emphasizes, among other features, low-fat dairy products; and the fruit/vegetable (FV) and control diets, each with 15% energy from protein. OUTCOME: AER. MEASUREMENTS: We measured AER by using immunoassay and covariates at baseline and after 8 weeks. RESULTS: Baseline AER had a geometric mean value of 4.0 +/- 0.2 (SE) mg/24 h. In 285 participants with baseline AER less than 7 mg/24 h, AER was unchanged by diet treatment (geometric mean, 2.5 +/- 0.2 mg/24 h in the control diet, 3.0 +/- 0.2 mg/24 h in the FV diet, and 2.8 +/- 0.2 mg/24 h in the DASH diet). Conversely, in 93 participants with baseline AER of 7 mg/24 h or greater, end-of-feeding AER was lower in the FV diet (6.6 +/- 1.0 mg/24 h) than in the control (11.4 +/- 1.8 mg/24 h; P = 0.01) or DASH diets (11.7 +/- 1.6 mg/24 h; P = 0.005). The DASH and control diets were not different (P = 0.9). LIMITATIONS: Long-term AER change not studied. CONCLUSIONS: The decrease in AER after 8 weeks occurred in only those with high-normal baseline AER in the FV diet, in a pattern distinct from the blood pressure decrease. The DASH diet did not increase AER despite a 3% increase in energy from protein.
RCT Entities:
BACKGROUND: Dietary studies designed to decrease the urinary albumin excretion rate (AER) typically reduce protein by increasing lower protein plant foods and decreasing higher protein animal products. STUDY DESIGN: We evaluated AER while increasing protein intake in the Dietary Approaches to Stop Hypertension (DASH) Trial (randomized, parallel group, 8 week controlled feeding). SETTING & PARTICIPANTS: 378 individuals without diabetes with prehypertension or stage I hypertension. INTERVENTION: The DASH diet, 18% energy from protein, emphasizes, among other features, low-fat dairy products; and the fruit/vegetable (FV) and control diets, each with 15% energy from protein. OUTCOME: AER. MEASUREMENTS: We measured AER by using immunoassay and covariates at baseline and after 8 weeks. RESULTS: Baseline AER had a geometric mean value of 4.0 +/- 0.2 (SE) mg/24 h. In 285 participants with baseline AER less than 7 mg/24 h, AER was unchanged by diet treatment (geometric mean, 2.5 +/- 0.2 mg/24 h in the control diet, 3.0 +/- 0.2 mg/24 h in the FV diet, and 2.8 +/- 0.2 mg/24 h in the DASH diet). Conversely, in 93 participants with baseline AER of 7 mg/24 h or greater, end-of-feeding AER was lower in the FV diet (6.6 +/- 1.0 mg/24 h) than in the control (11.4 +/- 1.8 mg/24 h; P = 0.01) or DASH diets (11.7 +/- 1.6 mg/24 h; P = 0.005). The DASH and control diets were not different (P = 0.9). LIMITATIONS: Long-term AER change not studied. CONCLUSIONS: The decrease in AER after 8 weeks occurred in only those with high-normal baseline AER in the FV diet, in a pattern distinct from the blood pressure decrease. The DASH diet did not increase AER despite a 3% increase in energy from protein.
Authors: Madelyn L Wheeler; S Edwin Fineberg; Naomi S Fineberg; Reid G Gibson; Laurie L Hackward Journal: Diabetes Care Date: 2002-08 Impact factor: 19.112
Authors: Johan Arnlöv; Jane C Evans; James B Meigs; Thomas J Wang; Caroline S Fox; Daniel Levy; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan Journal: Circulation Date: 2005-08-08 Impact factor: 29.690
Authors: H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf Journal: JAMA Date: 2001-07-25 Impact factor: 56.272
Authors: David R Jacobs; Maureen A Murtaugh; Michael Steffes; Xinhua Yu; Jeffrey Roseman; Frederick C Goetz Journal: Am J Epidemiol Date: 2002-06-15 Impact factor: 4.897
Authors: Hyunju Kim; Laura E Caulfield; Vanessa Garcia-Larsen; Lyn M Steffen; Morgan E Grams; Josef Coresh; Casey M Rebholz Journal: Clin J Am Soc Nephrol Date: 2019-04-25 Impact factor: 8.237
Authors: Holly J Kramer; Raymond R Townsend; Karen Griffin; Joseph T Flynn; Daniel E Weiner; Michael V Rocco; Michael J Choi; Matthew R Weir; Tara I Chang; Rajiv Agarwal; Srinivasan Beddhu Journal: Am J Kidney Dis Date: 2019-04 Impact factor: 8.860
Authors: Alex Chang; Linda Van Horn; David R Jacobs; Kiang Liu; Paul Muntner; Britt Newsome; David A Shoham; Ramon Durazo-Arvizu; Kirsten Bibbins-Domingo; Jared Reis; Holly Kramer Journal: Am J Kidney Dis Date: 2013-04-17 Impact factor: 8.860
Authors: Alex Chang; Bryan C Batch; Heather L McGuire; William M Vollmer; Laura P Svetkey; Crystal C Tyson; Anawin Sanguankeo; Cheryl Anderson; Jessica Houston; Lawrence J Appel Journal: Am J Kidney Dis Date: 2013-06-28 Impact factor: 8.860
Authors: Jaimon T Kelly; Suetonia C Palmer; Shu Ning Wai; Marinella Ruospo; Juan-Jesus Carrero; Katrina L Campbell; Giovanni F M Strippoli Journal: Clin J Am Soc Nephrol Date: 2016-12-08 Impact factor: 8.237